Market doldrums got you down? Air cargo global slump making you depressed? Cancelling some cargo flights or watching only partial loads taking off with reduced yields? Well, just like the old rock...

The results of PharmaMar's (MSE: PHM) Phase II study with lurbinectedin as a single agent for the treatment of relapsed small cell lung cancer were presented today to the American Society of...

Nektar Therapeutics (Nasdaq: NKTR) announced today that biomarker and clinical data from PIVOT-02 is being presented at the 2019 American Society of Clinical Oncology (ASCO) Meeting in Chicago,...

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing potential new therapies for cancer, today announced data presented at ASCO 2019 from an...

Public health nutrition professionals at Vitamin Angels, 1,000 Days, Sight & Life and Children's Investment Fund (CIFF) will address the global problem of maternal undernutrition and the case for...